SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and ...

Tonix Pharmaceuticals has launched Tonmya (cyclobenzaprine), a newly approved oral treatment for adults with fibromyalgia.

Sandoz has announced that Tyruko, the first and only FDA-approved biosimilar for multiple sclerosis (MS), is now available in ...

Markets and regulators will keep shifting, but an agile medical affairs function, built on flexible resourcing and ...

Over the past six decades, anti-thrombotic drug therapies have undergone a revolution, leading to major improvements in ...

Can you believe there are still outdated myths about the strategic value Medical Affairs (MA) brings to the table? There’s ...

Systematic literature reviews (SLRs) are a resource heavy, time-consuming but necessary part of evidence generation. SLRs present an opportunity for artificial intelligence (AI) to deliver significant ...

ESMO celebrates 50 years of focusing on oncology research; Improving cardiovascular disease therapy; Global pharma pricing ...

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led ...

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that ...

Johnson & Johnson (J&J) has announced new data showing that Tremfya (guselkumab) reduces symptoms of psoriatic arthritis (PsA ...